Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sol Carriazo

Showing results (1-10 of 46) with videos related to

Pageof 5
Sort By:
Clinical Kidney Journal|July 27, 2022
Wasp stings and plasma exchangeSol Carriazo, Alberto Ortiz
Clinical Kidney Journal|February 10, 2021
European East-West divide in kidney disease: the need to understand the drivers of chronic kidney disease outcomesSol Carriazo, Alberto Ortiz
Clinical Kidney Journal|February 25, 2022
The last pre-pandemic European Renal Association Registry report: age at start of kidney replacement therapy in EuropeSol Carriazo, Alberto Ortiz
Clinical Kidney Journal|June 6, 2022
Stopping kidney protection in the elderly following acute kidney injury: think mortalitySol Carriazo, Alberto Ortiz
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|June 21, 2024
A Close Look at Metabolic Dysfunction in Autosomal Dominant Polycystic Kidney Disease: From Bench to ImagingSol Carriazo, York Pei
Clinical Journal of the American Society of Nephrology : CJASN|March 13, 2025
Do Overweight Status and Obesity Affect Progression to ESKD in Autosomal Dominant Polycystic Kidney Disease?Sol Carriazo, York Pei
Journal of the American Society of Nephrology : JASN|March 31, 2026
Improving Early Risk Prediction for Autosomal Dominant Polycystic Kidney DiseaseSol Carriazo, York Pei
Clinical Kidney Journal|February 24, 2022
More on the invisibility of chronic kidney disease… and countingSol Carriazo, Priscila Villalvazo, Alberto Ortiz
Clinical Kidney Journal|July 24, 2020
Kidney disease and electrolytes in COVID-19: more than meets the eyeSol Carriazo, Mehmet Kanbay, Alberto Ortiz
Annals of Internal Medicine|April 17, 2023
First-Line Therapy for Type 2 Diabetes With Sodium-Glucose Cotransporter-2 Inhibitors and Glucagon-Like Peptide-1 Receptor AgonistsSol Carriazo, Alberto Ortiz, Beatriz Fernandez-Fernandez
Pageof 5

Showing results (1-10 of 46) with videos related to

Sort By:
Pageof 5
Clinical Kidney Journal|July 27, 2022
Wasp stings and plasma exchangeSol Carriazo, Alberto Ortiz
Clinical Kidney Journal|February 10, 2021
European East-West divide in kidney disease: the need to understand the drivers of chronic kidney disease outcomesSol Carriazo, Alberto Ortiz
Clinical Kidney Journal|February 25, 2022
The last pre-pandemic European Renal Association Registry report: age at start of kidney replacement therapy in EuropeSol Carriazo, Alberto Ortiz
Clinical Kidney Journal|June 6, 2022
Stopping kidney protection in the elderly following acute kidney injury: think mortalitySol Carriazo, Alberto Ortiz
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|June 21, 2024
A Close Look at Metabolic Dysfunction in Autosomal Dominant Polycystic Kidney Disease: From Bench to ImagingSol Carriazo, York Pei
Clinical Journal of the American Society of Nephrology : CJASN|March 13, 2025
Do Overweight Status and Obesity Affect Progression to ESKD in Autosomal Dominant Polycystic Kidney Disease?Sol Carriazo, York Pei
Journal of the American Society of Nephrology : JASN|March 31, 2026
Improving Early Risk Prediction for Autosomal Dominant Polycystic Kidney DiseaseSol Carriazo, York Pei
Clinical Kidney Journal|February 24, 2022
More on the invisibility of chronic kidney disease… and countingSol Carriazo, Priscila Villalvazo, Alberto Ortiz
Clinical Kidney Journal|July 24, 2020
Kidney disease and electrolytes in COVID-19: more than meets the eyeSol Carriazo, Mehmet Kanbay, Alberto Ortiz
Annals of Internal Medicine|April 17, 2023
First-Line Therapy for Type 2 Diabetes With Sodium-Glucose Cotransporter-2 Inhibitors and Glucagon-Like Peptide-1 Receptor AgonistsSol Carriazo, Alberto Ortiz, Beatriz Fernandez-Fernandez
Pageof 5